AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

NVTIA® Ergothioneine for Healthy Aging and Skin Health

RecruitingNAAges 35 Years - 55 YearsAllEUROPEAN LIFE SCIENCE RESEARCH ASSOCIATION
💬

In plain words

What the trial is, and whether it could suit you

This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of NVTIA® Ergothioneine, a branded ergothioneine ingredient, on healthy aging biomarkers and skin health in healthy adults aged 40 to 65 years. Participants will receive either NVTIA® Ergothioneine or a matching placebo once daily for 12 weeks. The primary objective of this study is to evaluate the effects of NVTIA® Ergothioneine supplementation on biomarkers associated with oxidative stress and healthy aging. Secondary objectives include assessment of skin elasticity, skin hydration, inflammatory biomarkers, and overall safety. The findings of this study are expected to provide clinical evidence supporting the role of NVTIA® Ergothioneine in promoting healthy aging and maintaining skin health.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Participants must meet all of the following criteria: * Male or female adults aged 35 to 55 years. * Generally healthy as determined by medical history, physical examination, and screening assessments. * Body Mass Index (BMI) between 18.5 and 29.9 kg/m². * Willing and able to provide written informed consent. * Willing to maintain their usual diet, physical activity, and lifestyle throughout the study period. * Willing to avoid the use of other antioxidant, anti-aging, or nutritional supplements during the study period unless approved by the investigator. * Able and willing to comply with all study procedures and scheduled visits. Exclusion Criteria: * Participants meeting any of the following criteria will be excluded: * History of clinically significant cardiovascular, hepatic, renal, gastrointestinal, endocrine, neurological, or psychiatric disease. * Current diagnosis of diabetes mellitus requiring medication. * Active inflammatory or autoimmune disease. * History of malignant disease within the previous five years. * Pregnancy, breastfeeding, or planning pregnancy during the study period. * Known allergy or hypersensitivity to ergothioneine or any ingredient of the study product. * Use of antioxidant supplements, anti-aging supplements, or investigational products within 30 days before enrollment. * Current smoker or history of heavy alcohol consumption. * Participation in another clinical trial within the previous 30 days. * Any medical condition or laboratory abnormality that, in the opinion of the investigator, may interfere with study participation or interpretation of study results.
💊

What it tests

  • NVTIA® Ergothioneine
  • Placebo
📍

Where

1 site
Dhaka Central International Medical College & Hospital
Dhaka, Bangladesh
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy